|
70 (PB058): Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-tyrosine kinase inhibitor (TKI), in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung cancer (NSCLC) |
|
|
|
Titel: |
70 (PB058): Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-tyrosine kinase inhibitor (TKI), in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung cancer (NSCLC) |
Auteur: |
Lim, S.M. Cho, B.C. Han, J.Y. Kim, S.W. Lee, K.H. Nagasaka, M. Jo, A. Seah, E. Kim, C. Reungwetwattana, T. |
Verschenen in: |
European journal of cancer |
Paginering: |
Jaargang 211 () nr. S1 pagina's p. |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Elsevier LTD. All rights reserved. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|